Engdologix (ELGX) CFO Buys 150K Shares
Engdologix (Nasdaq: ELGX) CFO, John Krist purchased 150,000 shares on 8/14-8/15 at prices ranging from $2.42-$2.45, bringing his stake to 226,899 shares.
Endologix, Inc. engages in the development, manufacture, sale, and marketing of minimally invasive therapies for the treatment of vascular diseases.
Related Categories
Insider TradesStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
